Urinary Catheters Market

The Future of the Urinary Catheters Market: Why Intermittent Catheters Are Growing Rapidly

The global healthcare industry is witnessing a major transformation in chronic urinary management, and the urinary catheters market is at the center of this evolution. Rising geriatric populations, increasing prevalence of urinary incontinence, neurological disorders, spinal cord injuries, and post-surgical urinary complications are accelerating demand for advanced catheterization solutions worldwide.

Among all product categories, intermittent catheters are emerging as the fastest-growing segment within the urinary catheters market. Healthcare providers, hospitals, rehabilitation centers, and home-care patients are increasingly adopting intermittent catheterization because of its lower infection risk, improved patient comfort, and compatibility with home healthcare environments.

According to recent industry analysis, the global urinary catheters market was valued at USD 6.8 billion in 2025 and is projected to reach USD 11.9 billion by 2035, growing at a CAGR of 5.8% during the forecast period. A significant portion of this growth is expected to come from intermittent catheter technologies, especially hydrophilic-coated and self-catheterization systems.

This article explores why intermittent catheters are gaining rapid traction, how technological innovation is reshaping the industry, and what the future holds for the global urinary catheters market.

Understanding the Urinary Catheters Market

Urinary catheters are medical devices used to drain urine from the bladder when patients are unable to urinate naturally. These devices are widely utilized across hospitals, ambulatory surgical centers, rehabilitation facilities, and home-care settings.

The urinary catheters market is broadly segmented into:

• Indwelling catheters
• Intermittent catheters
• External catheters

For decades, indwelling catheters dominated healthcare procurement because they were widely integrated into surgical recovery and intensive care workflows. However, growing awareness regarding catheter-associated urinary tract infections (CAUTIs) and patient discomfort has significantly changed clinical preferences.

Today, intermittent catheters are increasingly viewed as safer, more patient-friendly, and clinically efficient alternatives.

What Are Intermittent Catheters?

Intermittent catheters are temporary-use urinary catheters inserted several times daily to empty the bladder and then removed immediately afterward. Unlike indwelling Foley catheters, intermittent catheters are not continuously left inside the body.

These products are commonly used for:

• Urinary retention
• Neurogenic bladder dysfunction
• Spinal cord injuries
• Multiple sclerosis
• Benign prostatic hyperplasia
• Post-surgical bladder management
• Chronic urinary incontinence

Intermittent catheterization enables patients to maintain better mobility, hygiene, and independence, particularly in home-care settings.

Why Intermittent Catheters Are Growing Rapidly

Rising Awareness About Catheter-Associated Urinary Tract Infections

One of the biggest drivers behind intermittent catheter adoption is the increasing focus on reducing catheter-associated urinary tract infections.

CAUTIs remain among the most common hospital-acquired infections globally. Long-term indwelling catheter usage increases bacterial colonization risk, which can lead to severe complications, prolonged hospitalization, and higher healthcare costs.

Intermittent catheterization significantly lowers these risks because the catheter is removed immediately after bladder drainage. As hospitals intensify infection-control protocols, healthcare providers are shifting toward intermittent catheter systems whenever clinically appropriate.

This trend is reshaping procurement decisions across the global urinary catheters market.

Expansion of Home Healthcare Services

The rapid expansion of home healthcare infrastructure is another major growth catalyst for intermittent catheters.

Healthcare systems worldwide are reducing dependence on prolonged inpatient care and encouraging decentralized chronic disease management. As a result, patients increasingly prefer self-catheterization solutions that offer convenience, privacy, and reduced hospitalization dependency.

Intermittent catheters align perfectly with this healthcare transition because they are:

• Portable
• Easy to use
• Hygienic
• Discreet
• Suitable for self-administration

The rise of direct-to-patient distribution channels and online medical supply platforms is also supporting the growth of intermittent catheterization products globally.

Technological Advancements in Hydrophilic Catheters

Technology innovation is dramatically improving the performance and comfort of intermittent catheters.

Hydrophilic-coated catheters are among the most significant advancements in the urinary catheters market. These products feature a lubricated surface that becomes smooth when activated by water, reducing insertion friction and urethral trauma.

Benefits of hydrophilic intermittent catheters include:

• Lower infection risk
• Improved insertion comfort
• Reduced urethral irritation
• Better patient compliance
• Lower complication rates

Healthcare providers increasingly prioritize hydrophilic-coated catheter systems because outcome-based healthcare models now emphasize patient comfort and infection prevention.

This shift is enabling premium catheter manufacturers to strengthen pricing power within the urinary catheters market.

Aging Population Is Expanding Long-Term Demand

The global geriatric population continues to grow rapidly, creating sustained long-term demand for urinary catheterization products.

Elderly individuals are more susceptible to:

• Urinary incontinence
• Mobility disorders
• Neurological conditions
• Benign prostatic hyperplasia
• Bladder dysfunction

Many aging patients require recurring bladder management support across rehabilitation facilities, assisted-living environments, and home-care settings.

Intermittent catheterization is becoming increasingly popular among elderly patients because it offers greater comfort and lower infection exposure compared to long-term indwelling catheter usage.

Countries such as Japan, Germany, Italy, China, and the United States are expected to remain major contributors to urinary catheters market growth due to aging demographic structures.

Shift Toward Patient-Centric Healthcare

Modern healthcare systems are increasingly emphasizing patient autonomy and quality of life.

Traditional catheterization methods often created discomfort, restricted mobility, and increased dependency on institutional care. Intermittent catheters, by contrast, support independent bladder management and greater patient freedom.

Manufacturers are now developing:

• Compact travel-friendly catheters
• Pre-lubricated systems
• Closed-system catheterization products
• Female-specific catheter designs
• Pediatric intermittent catheter systems

These innovations are helping suppliers differentiate themselves within an increasingly competitive urinary catheters market.

Growth of Silicone-Based Intermittent Catheters

Silicone catheters are gaining strong commercial traction due to their superior biocompatibility and reduced allergy risks.

Compared to latex products, silicone intermittent catheters offer:

• Better flexibility
• Lower irritation
• Longer usability
• Reduced allergic reactions
• Enhanced patient comfort

As hospitals and home-care providers prioritize safer long-term catheterization options, silicone-based intermittent catheters are becoming preferred solutions across developed healthcare markets.

The growing preference for silicone materials is expected to remain a key trend shaping the urinary catheters market through 2035.

Regional Outlook of the Urinary Catheters Market

North America

North America currently dominates the urinary catheters market due to:

• Advanced healthcare infrastructure
• Strong reimbursement systems
• High surgical procedure volumes
• Broad adoption of premium catheter technologies

The United States represents the largest regional demand center because healthcare institutions actively prioritize infection-control initiatives and clinically differentiated catheter products.

Europe

Europe maintains a technologically advanced urinary catheters market driven by:

• Aging populations
• Long-term care expansion
• Stringent healthcare regulations
• Infection-prevention mandates

Countries such as Germany, France, and the United Kingdom are leading adopters of hydrophilic and antimicrobial catheter systems.

Asia Pacific

Asia Pacific is projected to register the fastest growth in the urinary catheters market during the forecast period.

Key growth drivers include:

• Healthcare infrastructure investments
• Rising surgical procedure volumes
• Expanding elderly populations
• Improving urology care accessibility
• Local medical device manufacturing growth

China, India, Japan, and Southeast Asian countries are expected to become major contributors to global intermittent catheter demand.

Competitive Landscape and Industry Innovation

The urinary catheters market remains moderately consolidated, with major players focusing heavily on innovation, infection prevention, and home-care optimization.

Leading companies operating in the market include:

• Becton, Dickinson and Company
• Coloplast A/S
• Teleflex Incorporated
• B. Braun SE
• Hollister Incorporated
• Convatec Group plc
• Cardinal Health
• Medtronic plc
• Cook Medical
• Boston Scientific Corporation

Competition increasingly centers on:

• Hydrophilic coating technologies
• Antimicrobial surface engineering
• Silicone-based catheter systems
• Patient comfort optimization
• Direct-to-patient distribution capabilities

Manufacturers investing in infection-resistant technologies and user-friendly intermittent catheter designs are expected to capture substantial market share over the next decade.

The Role of Smart Technologies in Future Catheter Development

Digital healthcare integration is beginning to influence the future of urinary catheter technologies.

Emerging innovation areas include:

• Smart catheter monitoring systems
• AI-assisted patient monitoring
• Digital urine output tracking
• Connected chronic care platforms
• Remote patient management integration

Although still in early-stage commercialization, connected catheter technologies could transform chronic bladder management over the long term.

Healthcare providers are increasingly interested in monitoring systems capable of improving patient compliance and reducing hospital readmissions.

Challenges Facing the Urinary Catheters Market

Despite strong growth potential, the urinary catheters market continues facing several operational and regulatory challenges.

Regulatory Complexity

Manufacturers must comply with extensive regulatory requirements related to:

• Sterility validation
• Biocompatibility testing
• Labeling standards
• Product safety documentation

Regulatory frameworks across the United States, Europe, and Asia-Pacific continue becoming more stringent, increasing compliance costs for suppliers.

Pricing Pressure

Public healthcare systems often prioritize cost efficiency during procurement processes, limiting pricing flexibility for manufacturers.

Tender-based procurement environments in emerging economies create additional competitive pressure within the urinary catheters market.

Supply Chain Disruptions

Medical-grade polymer availability, sterilization infrastructure, and logistics disruptions continue influencing production economics across the industry.

Manufacturers are increasingly regionalizing supply chains to improve resilience against geopolitical and transportation-related disruptions.

Future Outlook of the Urinary Catheters Market

The future outlook for the urinary catheters market remains highly positive.

Demand visibility is supported by multiple structural healthcare trends, including:

• Population aging
• Rising chronic disease burden
• Expansion of long-term care facilities
• Growth of home healthcare services
• Increasing awareness regarding infection prevention
• Technological advancements in hydrophilic and silicone catheters

Intermittent catheters are expected to remain the fastest-growing product segment because they align closely with modern healthcare priorities centered around patient safety, mobility, and decentralized care delivery.

Healthcare providers increasingly recognize that intermittent catheterization can improve patient outcomes while simultaneously lowering infection-related healthcare costs.

As reimbursement frameworks evolve and home healthcare ecosystems continue expanding, intermittent catheter adoption is likely to accelerate further across both developed and emerging markets.

Conclusion

The urinary catheters market is undergoing a major transformation driven by technological innovation, infection-prevention priorities, and changing patient care models.

Among all product categories, intermittent catheters are emerging as the strongest long-term growth opportunity due to their clinical advantages, lower infection exposure, and compatibility with home-based healthcare delivery.

Hydrophilic coatings, silicone engineering, portable catheter designs, and patient-centric innovation are reshaping the competitive landscape while creating new revenue opportunities for manufacturers worldwide.

With the global urinary catheters market projected to reach USD 11.9 billion by 2035, stakeholders across healthcare, medical devices, and investment sectors are increasingly focusing on intermittent catheter technologies as a critical growth engine within the broader urology care ecosystem.

As healthcare systems continue transitioning toward decentralized, outcome-focused care models, intermittent catheters are expected to play a defining role in the future of urinary management worldwide.